Improved scalability, sensitivity, and interpretability of pathogen detection, including SARS-CoV-2, in wastewater using high-throughput, highly multiplexed digital array PCR technology
使用高通量、高度多重数字阵列 PCR 技术提高废水中病原体检测(包括 SARS-CoV-2)的可扩展性、灵敏度和可解释性
基本信息
- 批准号:10264252
- 负责人:
- 金额:$ 99.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-01-01 至 2023-12-31
- 项目状态:已结题
- 来源:
- 关键词:2019-nCoVAddressBiological AssayBlood CirculationBusinessesCOVID-19COVID-19 pandemicClinicalCommunicable DiseasesCommunitiesConsumptionCoronavirusDataData AnalysesDevelopmentDiseaseDisease SurveillanceEducationFecesFutureGeographic LocationsGeographyGoalsHealthHomeHourHumanIndividualLaboratoriesLocationMethodsMolecularMonitorPathogen detectionPatientsPerformancePlantsPlayPrecipitationPrevalencePublic HealthQuality ControlReactionReportingResearchRespiratory distressRoleSamplingSchoolsSewageSourceSystemTechnologyTestingTimeVaccinationVaccinesVirusVisionbiomarker panelcostdigitalemerging pathogengastrointestinalgenetic testinghealth managementhealth warningimprovedmethod developmentmolecular markermultiplex assaynovelnovel coronaviruspandemic diseasepathogenresearch clinical testingrespiratoryresponsetooltransmission processviral RNAwastewater epidemiologywastewater monitoringwastewater samples
项目摘要
PROJECT ABSTRACT
Presently, the application of molecular technology such as RT-qPCR and digital PCR (dPCR) to quantify
SARS-CoV-2 and related targets in wastewater is cumbersome, time consuming, and costly. While
progress has been made on the development of methods and the interpretation of data, much remains to
be improved for the technology to be used as a public health management tool. A major drawback in the
current approaches are 1) the lack of streamlined and consistent pre-analytical processing steps, 2)
coverage across the relevant targets requires a high number of reactions (>20) from any single sample to
provide quantitative information, and 3) a lack of vision on the development of a pathogen/marker panel,
much like those used in clinical arenas, for interpretation of the data across different states, regions and
nations. The goal of this project will be to successfully navigate these three limitations toward
development of a public health warning system that is not dependent on clinical testing and has the ability
to rapidly address novel pathogen threats in the future.
项目摘要
目前,应用分子技术如RT-qPCR和数字PCR(dPCR)来定量
废水中的SARS-CoV-2和相关靶标是繁琐、耗时且昂贵的。而
在方法的发展和数据的解释方面已经取得了进展,但仍有许多工作要做。
该技术将作为公共卫生管理工具加以改进。一个主要的缺点,
目前的方法是1)缺乏精简和一致的分析前处理步骤,2)
覆盖相关靶标需要来自任何单个样品的大量反应(>20),
提供定量信息,和3)缺乏对病原体/标志物小组发展的远见,
就像临床领域使用的那些,用于解释不同州、地区和
nations.本项目的目标是成功地驾驭这三个限制,
开发一个公共卫生预警系统,该系统不依赖于临床测试,
来快速应对未来新的病原体威胁。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Rachel Todd Noble其他文献
Rachel Todd Noble的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Rachel Todd Noble', 18)}}的其他基金
Improved scalability, sensitivity, and interpretability of pathogen detection, including SARS-CoV-2, in wastewater using high-throughput, highly multiplexed digital array PCR technology
使用高通量、高度多重数字阵列 PCR 技术提高废水中病原体检测(包括 SARS-CoV-2)的可扩展性、灵敏度和可解释性
- 批准号:
10320994 - 财政年份:2021
- 资助金额:
$ 99.75万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 99.75万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 99.75万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 99.75万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 99.75万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 99.75万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 99.75万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 99.75万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 99.75万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 99.75万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 99.75万 - 项目类别:
Research Grant